HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequency of the polymorphonuclear neutrophil Fc gamma receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia.

Abstract
We report the case of a healthy woman (K.M.) who, after multiple pregnancies, developed an antibody directed against a nonpolymorphic region of the polymorphonuclear neutrophil (PMN) Fc gamma receptor III (FcRIII-CD16), which caused transient neonatal alloimmune neutropenia (NAIN). The antigenic target of the antibody was determined by an immunoprecipitation procedure and by phenotyping the mother's PMN. These latter did not react with monoclonal CD16 or polyclonal and monoclonal NA1 and NA2 antibodies, demonstrating the absence of PMN-FcRIII and, consequently, the NA-null phenotype. We also determined the frequency of the NA-null phenotype in a healthy, white population. Among 3,377 random blood donors, only four (in addition to K.M.) were PMN-FcRIII-deficient. These five individuals were healthy and only one (K.M.) presented an allo-CD16 antibody. The gene frequency of the NA-null phenotype was calculated as 0.0274 +/- 0.0059. We conclude that PMN-FcRIII deficiency is a rare phenomenon that can lead to CD16 alloimmunization and thus cause NAIN.
AuthorsP Fromont, A Bettaieb, H Skouri, C Floch, E Poulet, N Duedari, P Bierling
JournalBlood (Blood) Vol. 79 Issue 8 Pg. 2131-4 (Apr 15 1992) ISSN: 0006-4971 [Print] United States
PMID1532916 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation
  • Receptors, Fc
  • Receptors, IgG
Topics
  • Antigens, CD (genetics)
  • Antigens, Differentiation (analysis, genetics)
  • Autoimmune Diseases (epidemiology, genetics)
  • Female
  • France (epidemiology)
  • Gene Frequency
  • Humans
  • Infant, Newborn
  • Neutropenia (epidemiology, genetics, immunology)
  • Neutrophils (immunology)
  • Phenotype
  • Receptors, Fc (analysis, genetics)
  • Receptors, IgG
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: